[Interferon-beta in treatment of relapsing multiple sclerosis].
Hartung
H P
HP
Klinische Forschungsgruppe für Multiple Sklerose und Neurologische Klinik, Julius-Maximilians Universität Würzburg.
Hohlfeld
R
R
D000293:Adolescent; D000328:Adult; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000628:therapy*; D009460:Neurologic Examination / Q000187:drug effects
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a
Interferon-beta zur Behandlung der schubförmig verlaufenden Multiplen Sklerose.